Last reviewed · How we verify
Placebo Folliculinum — Competitive Intelligence Brief
phase 3
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo Folliculinum (Placebo Folliculinum) — Shaare Zedek Medical Center. The exact mechanism of action of Folliculinum is not well understood.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo Folliculinum TARGET | Placebo Folliculinum | Shaare Zedek Medical Center | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo Folliculinum CI watch — RSS
- Placebo Folliculinum CI watch — Atom
- Placebo Folliculinum CI watch — JSON
- Placebo Folliculinum alone — RSS
Cite this brief
Drug Landscape (2026). Placebo Folliculinum — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-folliculinum. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab